Drugs / Monovalent Influenza Subvirion Vaccine, H7N7
last change Mar 2014 re-read 3 minutes ago

Monovalent Influenza Subvirion Vaccine, H7N7

Vaccine

Developed for
avian influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01534468 Mar 2012 → Mar 2014 avian influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Monovalent Influenza Subvirion Vaccine, H7N7 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01534468 ↗
Modality Vaccine “H7N7 vaccine” NCT01534468 ↗
Route Intramuscular “one intramuscular (IM) injection” NCT01534468 ↗